ClinicalTrials.gg
RecruitingNCT06827951Updated Nov 17, 2026

Potential Benefits of Parent Child Interaction Therapy (PCIT)

An observational study in Autonomic Dysregulation, Anxiety and Depression, sponsored by University of Florida. Recruiting at 2 sites in United States. Open to participants aged 18 Years to 89 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.

Primary conditionDepressionRegistry: Anxiety DisordersReclassifiedWhy we changed it
Registry
Anxiety Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Depression
Why
  1. The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it.
  2. The study's listed conditions name Depression.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of Florida · Observational

How we know

From the registry’s dates

  • Started Feb 2025; still recruiting 1 year 9 months later.
Updated Nov 17, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
80
Ages
18 Years to 89 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 13 studies in Depression by University of Florida — 3 open to participants now, 4 under way, 1 of them phase 3. Depression · University of Florida.

Started
2025
with 2 others
Observational
3 of 13
1 open now
Registered
9th of 13
by date

Among the 13 studies in Depression by University of Florida, this one is one of 3 that started in 2025, is one of 3 observational ones, and was the 9th registered.

Depression

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

Browse Depression studies →

Open to participants now

3 of the 13 studies in Depression by University of Florida are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: 18 Years to 89 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Depression by University of Florida, or all of them as a file.
02

Study summary

The goal of this study is to explore possible benefits of Parent-Child Interaction Therapy (PCIT). The main goals of the study are:

  • To investigate whether pre-survey measures of autonomic reactivity relate to the overall functioning of participants.
  • To examine the effects of PCIT To identify individual characteristics that influence the effects of PCIT.

Participants will:

  • complete 5 online surveys (1x pre-PCIT, 3x during PCIT, and 1x post-PCIT)
  • complete the PCIT program
Read the detailed description

It is the specific intent of this proposal to experimentally explore the possible benefits and mechanisms through which PCIT can influence self-reported stress and autonomic and neuroendocrine functioning in parents. This will be accomplished by our team by using well-validated self-report measures of mental health, autonomic reactivity, parental stress and attachment, and non-invasive measurements of levels of oxytocin.

Specific Aim 1: To investigate whether pre-intervention measures of ANS reactivity and the neuropeptides oxytocin relate to the overall functioning of the participants.

  • The investigators will examine how measures of autonomic reactivity and levels of oxytocin relate to prior mental/medical health.
  • Hypothesis: Participants with lower levels of oxytocin and/or increased autonomic reactivity will report being more impacted by their prior adversity and having more emotional/physical symptoms.

Specific Aim 2: To investigate the impact of PCIT

  • The investigators will explore whether PCIT leads to improvements in parental stress, parent-child attachment, and parental neuroendocrine functioning.
  • Hypothesis: Parents will show a significant decrease in perceived stress and improvement in emotional wellbeing oxytocin levels following CDI. They will also show a decrease in perceived stress, and improvement in attachment and emotional wellbeing following the entire PCIT intervention.

Specific Aim 3: To identify individual characteristics that influence the effectiveness of PCIT.

  • The investigators will explore the impact of specific vulnerability and resiliency factors (e.g., stress, prior adversity) on how well parents benefit from PCIT
  • Hypothesis: Parental stress and prior mental/medical adversity will negatively impact the effectiveness of intervention
03

Conditions studied

  • Autonomic Dysregulation
  • Anxiety
  • Depression
  • Parent-Child Relations

Browse trials for

Keywords

  • Polyvagal Theory
  • Adversity
  • Parent-Child Interaction Therapy
  • Attachment
  • Autonomic Reactivity
  • Oxytocin
04

In context

Depression Reclassified

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

This study's planned enrollment of 80 is below the median of 175 across 1,261 observational studies indexed under Depression.

Browse Depression studies →

Lead sponsor

University of Florida is the lead sponsor of 1,290 studies on the registry; 202 are open to participants now.

Of its 181 completed or terminated interventional studies of FDA-regulated products, 143 (79%) have results posted.

Compared within Depression, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Anxiety Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years to 89 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The investigators intend to recruit parents of children aged 2-7 with behavioral issues who are eligible for the PCIT program at two university clinics (UF Health Jacksonville and Shands Gainesville) specializing in child psychology and parent training. This population represents those most likely to experience stress and benefit from improved parent-child interactions and stress regulation

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Parents of children aged 2-7 years old who are eligible for Parent-Child Interaction Therapy (PCIT) based on behavioral concerns.
  • The primary caregiver of the child and be actively involved in the child's daily care.
  • Willing to attend all PCIT sessions and complete pre-, mid- and post-intervention assessments.
  • Fluent in English to ensure comprehension of the intervention and assessment materials.

Exclusion criteria

Exclusion Criteria:

  • Parents with diagnosed severe mental health disorders (e.g., schizophrenia, bipolar disorder) that may interfere with participation in PCIT.
  • Children with conditions that require interventions other than PCIT (e.g., severe developmental disabilities).
  • Parents who have previously participated in PCIT are excluded to avoid confounding results.
06

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
80 participants (estimated)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • PCIT Group

    All participants will complete the five online surveys and provide two saliva samples.

    Behavioral: Parent-Child Interaction Therapy (PCIT)

Interventions

  • BehavioralParent-Child Interaction Therapy (PCIT)

    Participants will undergo the standard PCIT program, which consists of two phases: Child-Directed Interaction (CDI) and Parent-Directed Interaction (PDI). * CDI Phase: Parents will learn and practice techniques that focus on strengthening the parent-child relationship through play and positive reinforcement. * PDI Phase: Parents will be coached in effective discipline strategies to manage their child's behavioral problems.

07

What researchers measure

Primary outcomes

  1. Measuring Change in Autonomic Reactivity using the Body Perceptions Inventory Short Form

    This 20-item measure is scored on a 5-point Likert scale (never = 1, occasionally = 2, sometimes = 3, usually = 4, always = 5). Items are summed to determine total autonomic reactivity score, with the higher scores indicating greater autonomic reactivity

    Time frame: Through study completion, an average of 20 weeks

  2. Assessing the Impact of Adversity History

    This measure assesses the impact of six types of traumatic experiences (childhood adverse experiences, childhood maltreatment, intimate partner maltreatment, other person maltreatment, life-threatening situations, sudden losses, and person health situations). Each item is scored on a 5-point Likert scale (did not occur = 0, occurred and no impact on my life = 1 to big impact on my life = 4). Items are summed to determine total impact scores.

    Time frame: Up to 1 week

  3. Measuring change in oxytocin Levels

    Oxytocin levels will be assessed using salivary samples. Increased salivary oxytocin indicates improvement.

    Time frame: Up to 4 weeks

  4. Measuring change in parental stress using the parental stress scale

    This 18-item questionnaire assesses parents' feelings about their parenting role via a 5-point Likert scale (Strongly disagree = 1 to Strongly agree = 5). Lower scores indicate lower levels of parental stress.

    Time frame: Through study completion, an average of 20 weeks

  5. Measuring change in parental attachment using the Child-Parent Relationship Scale

    This 30-item questionnaire assesses parents' views of their relationship with their child via a 5-point Likert scale (1 = definitely does not apply to 5 = definitively applies). The scores for the subscales (e.g., closeness, conflict, dependency) are calculated by summing the relevant items, with higher scores indicating more positive views of the relationship.

    Time frame: Through study completion, an average of 20 weeks

  6. Measuring change in child behavior using the parent-report Eyberg Child Behavior Inventory

    This 36-item measure assesses the frequency and severity of disruptive behaviors, as well as the extent to which parents find the behaviors troublesome via a 7-point Likert scale (1 Never Occurs to 7 = Always Occurs) and a binary Problem scale. Total Intensity Scale scores range from 36 to 352, with clinical cut-off scores of 131-133.

    Time frame: Through study completion, an average of 20 weeks

  7. Measuring change in anxiety using the General Anxiety Disorder-7

    This 7-item measure assesses anxiety via a 4-point Likert scale (0 = Not at all to 3 = Nearly every day) with higher scores reflecting more symptoms of anxiety.

    Time frame: Through study completion, an average of 20 weeks

  8. Measuring change in depression using the Patient Health Questionnaire-8

    This 8-item measure assesses depression via a 4-point Likert scale (0 = Not at all to 3 = Nearly every day) with higher scores reflecting more symptoms of depression.

    Time frame: Through study completion, an average of 20 weeks

  9. Measuring change in post-traumatic stress symptoms using the PTSD Checklist for DSM-5

    This 20-item measure assesses PTSD symptoms via a 5-point Likert (0 = Not at all to 4 = Extremely) with higher scores reflecting more symptoms of PTSD.

    Time frame: Up to 1 week

08

Study locations

2 of 2 sites recruiting
  • UF Health Child Psychiatry
    Gainesville, Florida 32606, United States
    Recruiting
    • Liliana L. Acosta, PhD · Contactlilianalacosta@ufl.edu · 352-294-4900
    • Liliana L Acosta, PhD · Principal investigator
  • UF Health Psychiatry San Jose
    Jacksonville, Florida 32217, United States
    Recruiting
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2025 (actual). Primary completion is estimated for Jun 2027, 27 months after the start.

Of 463 non-industry observational studies under Depression, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 63. This study's planned 27 months is below that.

Counting every sponsor, half of 496 studies reached it within 32 months; a quarter within 13 and three quarters within 61.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 17, 2026: primary completion Jun 2026 → Jun 2027 and completion Jun 2026 → Jun 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Nov 18, 2024
First posted
Feb 14, 2025
StartActual
Feb 14, 2025
Primary completionEst.
Jun 1, 2027was Jun 2026
CompletionEst.
Jun 1, 2027was Jun 2026
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jun 1, 2026→Jun 1, 2027
Nov 17, 2026
Study completion
Jun 1, 2026→Jun 1, 2027
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    Primary completion Jun 1, 2026→Jun 1, 2027
    Study completion Jun 1, 2026→Jun 1, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT06827951
Responsible party
Sponsor
First posted
Feb 14, 2025
Start date
Feb 14, 2025
Primary completion
Jun 1, 2027 (estimated)
Completion
Jun 1, 2027 (estimated)
Last update
Nov 17, 2026

Study contacts

Britney Duner, LCSW
Contact
Britney.Duner@jax.ufl.edu
(904) 383-1038
Kourtney Schroeder, PsyD
Contact
Kourtney.Schroeder@jax.ufl.edu
(904) 383-1038
Britney N. Duner, LCSW
principal investigator · University of Florida College of Medicine Jacksonville
Liliana L. Acosta, PhD
principal investigator · University of Florida

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion